The U.S. Food and Drug Administration has approved cefadroxil, cefixime, ceftibuten, and azithromycin for once-daily dosing in the treatment of GABHS pharyngitis. The population studied was children with an age of 4 to 18 years with suspected GABHS pharyngitis in a private pediatric practice....
BID dosing of strep tonsillopharyngitisMICHAEL G. BURKE